Synchrony Financial
SYF
$75.79
-1.79%
Synchrony Financial is the largest provider of private-label credit cards in the United States, offering retail card, payment solutions, and CareCredit financing for elective healthcare procedures. As a market leader in point-of-sale financing, it partners with major retailers and healthcare providers to drive consumer spending through its credit products. The current investor narrative centers on improving credit metrics and consumer resilience amid inflation, with a strong capital return program including aggressive share buybacks that signal management's confidence in the stock's value.…
SYF
Synchrony Financial
$75.79
Related headlines
Investment Opinion: Should I buy SYF Today?
Rating: Buy. Synchrony is a compelling value play with accelerating revenue growth, massive free cash flow, and a deeply discounted valuation. The consensus analyst rating is Buy (mean 1.83/5) with an average target of $89.13, implying 22.3% upside.
Supporting evidence: (1) Forward P/E of 6.9x is a 54% discount to the sector median of ~15x. (2) Revenue growth accelerated to 16.6% YoY in Q1 2026, the highest in recent quarters. (3) Trailing free cash flow of $9.834B yields ~33% of market cap. (4) ROE of 21.2% demonstrates efficient capital use. The stock is undervalued relative to its history and peers, with the low multiple pricing in excessive pessimism.
Risks & Conditions: The biggest risks are a spike in credit losses or a recession that reverses revenue growth. This Buy rating would be downgraded to Hold if net margins fall below 10% or if revenue growth decelerates below 5%. Conversely, it could be upgraded if the forward P/E expands above 10x as earnings materialize. Overall, Synchrony appears undervalued given its cash flow generation and growth trajectory.
Sign up to view all
SYF 12-Month Price Forecast
Synchrony's accelerating revenue growth and massive cash flow generation are not fully reflected in its deeply discounted valuation. The forward P/E of 6.9x implies the market is pricing in significant earnings risk, but if credit conditions remain stable, the stock offers substantial upside. The high short interest and technical underperformance are contrarian indicators that could reverse on positive catalysts. We would upgrade our stance if net margins stabilize above 15%, and downgrade if revenue growth decelerates below 5% or provisions rise sharply.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Synchrony Financial's 12-month outlook, with a consensus price target around $88.96 and implied upside of +17.4% versus the current price.
Average Target
$88.96
0 analysts
Implied Upside
+17.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$78 - $104
Analyst target range
Synchrony is covered by 23 analysts, with a consensus recommendation of 'Buy' (mean score 1.83 on a 1-5 scale where 1 is Strong Buy). The average target price is $89.13, implying 22.3% upside from the current price of $72.90. The distribution shows a bullish lean, with recent actions including HSBC and TD Cowen reiterating Buy ratings, while BTIG downgraded from Buy to Neutral in April 2026. The target range spans from $78.00 (low) to $104.00 (high), representing a 33% spread between low and high. The high target of $104 assumes multiple expansion and sustained earnings growth, while the low target of $78 implies only modest upside and reflects risks from consumer credit deterioration. The wide spread indicates high uncertainty among analysts. Recent upgrades from Barclays (Overweight) and Baird (Outperform) suggest positive sentiment, while JP Morgan and UBS remain Neutral. The strong buyback program and improving credit metrics are key catalysts supporting the bullish case.
Drowning in data?
Find the real signal!
Bulls vs Bears: SYF Investment Factors
Synchrony presents a compelling value opportunity with accelerating revenue growth, massive free cash flow, and a forward P/E of 6.9x that is deeply discounted versus the sector. The bull case is supported by strong capital returns and improving credit metrics, while the bear case centers on margin compression from rising provisions and persistent underperformance relative to the market. The single most important tension is whether revenue acceleration can sustain and provisions stabilize, which would validate the low valuation and drive multiple expansion. Currently, the evidence slightly favors the bull case given the strong cash flow and analyst consensus, but the stock's technical weakness and high short interest warrant caution.
Bullish
- Revenue growth accelerating to 16.6%: Q1 2026 revenue grew 16.6% YoY to $5.603B, a sharp acceleration from 4.7% in Q4 2025 and 3.1% in Q3 2025, driven by higher interest income and purchase volumes across retail card and payment solutions.
- Massive free cash flow generation: Trailing twelve-month free cash flow is $9.834B, yielding ~33% of the current market cap of $29.85B, providing ample capacity for dividends and aggressive share buybacks.
- Attractive valuation with 22% upside: Forward P/E of 6.9x is well below the sector median of ~15x, and the average analyst target of $89.13 implies 22.3% upside from the current price of $72.90.
- Strong capital return program: Synchrony is aggressively buying back shares, reducing share count from 385M in Q1 2025 to 342M in Q1 2026, a 11% reduction, signaling management's confidence in undervaluation.
Bearish
- Net margin compression from rising provisions: Net margin fell to 14.4% in Q1 2026 from 22.3% in Q3 2025, as higher provision expenses for credit losses ate into profitability, reflecting potential consumer credit stress.
- Stock underperforming S&P 500 significantly: SYF's 1-year price change of +1.5% drastically lags the S&P 500's +16.5%, with negative relative strength across all timeframes, indicating persistent market skepticism.
- High short interest at 5.15 days: Short ratio of 5.15 days suggests elevated bearish sentiment, with many investors betting against the stock, which could pressure the price if negative catalysts emerge.
- Cyclical sensitivity to consumer credit: As a consumer lender, Synchrony is highly exposed to economic downturns; a rise in unemployment or default rates could sharply reduce earnings, as seen in the net margin decline.
SYF Technical Analysis
Synchrony's stock is in a range-bound consolidation pattern, with a 1-year price change of +1.5% significantly underperforming the S&P 500's +16.5% gain. The current price of $72.90 sits at 42% of its 52-week range ($63.08–$88.77), indicating it is closer to the low end and potentially offering value if fundamentals support a recovery. This positioning near the lower half of the range suggests the market is pricing in caution rather than momentum. Short-term momentum is negative, with 1-month and 3-month price changes of -4.5% and -4.5%, respectively, diverging from the flat 1-year trend. This divergence could signal a temporary pullback within a broader consolidation, but the relative strength versus the S&P 500 is deeply negative (1-month relative strength -5.3%, 1-year -15.0%), confirming sustained underperformance. The stock's beta of 1.31 indicates 31% higher volatility than the market, amplifying both upside and downside moves. Key support lies at the 52-week low of $63.08, while resistance is at the 52-week high of $88.77. A breakout above $88.77 would signal a bullish reversal, while a breakdown below $63.08 could accelerate selling. The elevated short ratio of 5.15 days suggests bearish sentiment that could fuel a short squeeze on positive catalysts.
Beta
1.31
1.31x market volatility
Max Drawdown
-27.9%
Largest decline past year
52-Week Range
$63-$89
Price range past year
Annual Return
+8.8%
Cumulative gain past year
| Period | SYF Return | S&P 500 |
|---|---|---|
| 1m | -1.3% | +0.2% |
| 3m | +0.0% | +3.7% |
| 6m | +4.4% | +8.0% |
| 1y | +8.8% | +18.2% |
| ytd | -10.5% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SYF Fundamental Analysis
Synchrony's revenue trajectory is accelerating, with Q1 2026 revenue of $5.603 billion growing 16.6% year-over-year, up from 4.7% growth in Q4 2025 and 3.1% in Q3 2025. This acceleration is driven by higher interest income and purchase volumes across its retail card and payment solutions segments. The multi-quarter trend shows a clear inflection from low single-digit growth in 2024 to double-digit expansion in 2026, supporting the investment case for improving consumer spending and loan growth. Profitability is robust, with net income of $805 million in Q1 2026 and a net margin of 14.4%, though this is down from 22.3% in Q3 2025 due to higher provision expenses. Gross margin improved to 82.7% in Q1 2026 from 49.3% in Q4 2025, reflecting a favorable revenue mix shift. Operating margin of 16.3% is healthy but below the 29.6% peak in Q3 2025, indicating some margin compression from rising costs. The company generates strong free cash flow, with $2.183 billion in Q1 2026 and $9.834 billion in trailing twelve months. The debt-to-equity ratio of 0.91 is manageable, and ROE of 21.2% demonstrates efficient capital use. Free cash flow yield (based on market cap of $29.85 billion) is approximately 33%, indicating ample cash generation to support dividends and buybacks without external financing.
Quarterly Revenue
$5.6B
2026-03
Revenue YoY Growth
+16.6%
YoY Comparison
Gross Margin
82.7%
Latest Quarter
Free Cash Flow
$9.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SYF Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 8.9x, while the forward P/E is 6.9x, implying the market expects earnings growth of about 29% over the next year. This gap suggests optimism about future profitability improvements. Compared to the industry average (financial services sector), Synchrony's trailing P/E of 8.9x is at a discount to the sector median of approximately 15x, representing a 41% discount. This discount is justified by the cyclical nature of consumer credit and regulatory risks, but the low multiple also reflects market skepticism about earnings sustainability. Historically, Synchrony's trailing P/E has ranged from 3.3x (Q1 2024) to 10.1x (Q4 2025). The current 8.9x is near the upper end of its historical band, suggesting the market is pricing in relatively optimistic expectations. However, the forward P/E of 6.9x is below the historical average, indicating that if earnings materialize as expected, the stock could be undervalued.
PE
8.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 3x~10x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Synchrony's net margin has compressed from 22.3% in Q3 2025 to 14.4% in Q1 2026 due to rising provision expenses, indicating potential credit deterioration. The debt-to-equity ratio of 0.91 is manageable but elevated for a financial firm, and the current ratio of 0.21 is very low, reflecting the nature of its lending business. Revenue concentration in consumer credit makes it vulnerable to a spike in defaults, which could further pressure earnings and force higher loan loss reserves.
Market & Competitive Risks: The stock's beta of 1.31 implies 31% higher volatility than the market, amplifying downside in a selloff. With a trailing P/E of 8.9x near the high end of its historical range (3.3x-10.1x), there is limited room for multiple expansion if earnings disappoint. Competitive threats from fintech lenders and buy-now-pay-later services could erode market share, while regulatory scrutiny on credit card fees and interest rates remains a headwind. The stock's 1-year relative strength of -15% versus the S&P 500 confirms sustained underperformance.
Worst-Case Scenario: A sharp economic downturn causing consumer defaults to spike could drive Synchrony's earnings below expectations, leading to analyst downgrades and multiple compression. In such a scenario, the stock could fall to its 52-week low of $63.08, representing a 13.5% decline from the current price of $72.90. If credit losses exceed provisions, the stock could test even lower levels, with a potential downside of -27.9% (the historical max drawdown) to around $52.50.
FAQ
The primary risk is a deterioration in consumer credit quality, which would increase provisions and compress net margins further from the current 14.4%. Second, the stock's beta of 1.31 makes it more volatile than the market, amplifying losses in a downturn. Third, regulatory risks include potential caps on credit card late fees or interest rates. Fourth, competitive pressure from fintech lenders and buy-now-pay-later services could erode market share. The most severe risk is a recession causing a spike in defaults, potentially driving the stock to its 52-week low of $63.08.
Analysts forecast a 12-month price target range of $78 to $104, with an average of $89.13, implying 22% upside from the current $72.90. Our base case (50% probability) targets $78-$89, assuming revenue growth moderates to 8-10% and margins stabilize. The bull case (30% probability) targets $89-$104, driven by sustained revenue acceleration and multiple expansion. The bear case (20% probability) targets $63-$78, if credit losses spike. The most likely scenario is the base case, with the stock gradually re-rating as earnings materialize.
Synchrony appears undervalued based on its forward P/E of 6.9x, which is a 54% discount to the financial services sector median of ~15x. The trailing P/E of 8.9x is near the high end of its historical range (3.3x-10.1x), but the forward multiple suggests the market expects earnings growth of about 29% over the next year. Given the company's accelerating revenue growth (16.6% YoY) and strong free cash flow, the current valuation implies excessive pessimism about credit risks.
Synchrony is a good buy for value-oriented investors with a medium-term horizon, given its forward P/E of 6.9x, 22% upside to the average analyst target of $89.13, and massive free cash flow yield of 33%. However, the stock carries cyclical risk from consumer credit exposure, as evidenced by net margin compression from 22.3% to 14.4% over the past two quarters. The high short interest of 5.15 days adds uncertainty. For investors comfortable with this risk/reward profile, the current price offers an attractive entry point.
Synchrony is better suited for medium- to long-term investment (12-24 months) given its value orientation and cyclical nature. The stock's beta of 1.31 and high short interest make it volatile for short-term trading. The strong buyback program and dividend yield of 1.7% provide a total return cushion, but the primary catalyst is earnings growth and multiple expansion. A minimum holding period of 12 months is recommended to allow the revenue acceleration and credit trends to play out.
